Hope no one's affected, but just in case:
A Canadian drug distributor has issued an urgent recall for Alysena-28 birth control pills.
Apotex says one batch of the Alysena-28 may contain two weeks of placebo sugar pills instead of one, adding the error can reduce the effectiveness of the pills and raises the possibility of unplanned pregnancy.
The code on the recalled packages is LF01899A. The bad packages were distributed in all provinces except Saskatchewan and Alberta.
A friend of mine suggested that I write something from my point of view because, surprisingly, I manage to give an outwards impression of having my shit together. I was shocked to hear this. And I find this comical, but I see her point. I’m functioning. I’ve adapted. I’m surprisingly okay. I think the medical term is “resilient”.
So, here it is.
A very long article about the U.S. health care system. The author tries to "follow the money" and make sense of medical bills for several different people. Warning for depression because it's depressing.
TLDR; our system is fucked up and most of us are one bad illness or accident away from financial ruin. And this fact: "[The USA] spend[s] more on health care than the next 10 biggest spenders combined: Japan, Germany, France, China, the U.K., Italy, Canada, Brazil, Spain and Australia."
Many people say they want to lose weight to improve their health, but this may not actually be their primary motivation. In one poll, more than three-fourths of the 231 dieters surveyed said that they would take a pill that would guarantee they would achieve or maintain their desired weight even if it would lower their life expectancy. This is not so surprising when you consider weight-loss attempts for what they really are: efforts to protect against weight-based discrimination.
A new meta-analysis of the relationship between weight and mortality risk, involving nearly three million subjects from more than a dozen countries, found that all adults categorized as overweight and most of those categorized as obese have a lower mortality risk than so-called normal-weight individuals. If the government were to redefine normal weight as one that doesn’t increase the risk of death, then about 130 million of the 165 million American adults currently categorized as overweight and obese would be re-categorized as normal weight instead.
The FDA has withdrawn its approval of Teva Pharmaceutical's Budeprion XL 300-mg tablets, a generic version of GSK's Wellbutrin XL extended-relief antidepressant. Tests revealed that the generic does not act like a once-a-day formula but more like an immediate-release formula. The FDA had previously waived tests of the now-withdrawn 300 mg version based on tests of the lower dose 150 mg drug, which acts as intended and remains on the market.
The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.
The National Cancer Institute estimates that about 40 percent of women undergoing screening mammography have dense breasts. These women have an increased risk of breast cancer, with detection usually at a more advanced and difficult to treat stage.
Yet another lawsuit has been filed by an organization looking to deny its female employees access to healthcare, except this time it isn't a Catholic church, school, or charity— it's Hobby Lobby, a popular arts & crafts retail chain.
Rep. Todd Akin, the Republican nominee for Senate in Missouri who is running against Sen. Claire McCaskill, justified his opposition to abortion rights even in case of rape with a claim that victims of “legitimate rape” have unnamed biological defenses that prevent pregnancy.
“First of all, from what I understand from doctors [pregnancy from rape] is really rare,” Akin told KTVI-TV in an interview posted Sunday. “If it’s a legitimate rape, the female body has ways to try to shut that whole thing down.”
Why George Takei's fat shaming posts on his Facebook page are hypocritical.
